Finance

Lists
Why is 603456 up 7.85%?
Dive Deeper
603456:SHA
Zhejiang Jiuzhou Pharmaceutical Co Ltd
CNÂ¥16.21
+7.85%
(+1.18) 1D
Nov 4, 3:00:00 PM GMT+8  ·   CNY
All symbols
SymbolPriceChange% Change
Generating top insights for 603456...
Open
CNÂ¥15.05
High
CNÂ¥16.29
Low
CNÂ¥15.00
Mkt. cap
13.16B
Avg. vol.
21.42M
Volume
35.46M
Dividend
1.23%
Quarterly dividend
CNÂ¥0.05
Ex-dividend date
Sep 11, 2026
P/E ratio
24.16
52-wk high
CNÂ¥22.25
52-wk low
CNÂ¥12.05
EPS
CNÂ¥0.67
Shares outstanding
805.89M
No. of employees
5K
Open
CNÂ¥15.05
High
CNÂ¥16.29
Low
CNÂ¥15.00
Mkt. cap
13.16B
Avg. vol.
21.42M
Volume
35.46M
Dividend
1.23%
Quarterly dividend
CNÂ¥0.05
Ex-dividend date
Sep 11, 2026
P/E ratio
24.16
52-wk high
CNÂ¥22.25
52-wk low
CNÂ¥12.05
EPS
CNÂ¥0.67
Shares outstanding
805.89M
No. of employees
5K
News stories
From web sources and news partners
About Zhejiang Jiuzhou Pharmaceutical Co Ltd
CEO-
Employees4.79K
Founded1973
Headquarters-
SectorPharmaceutical industry
Industry-
Websitejiuzhoupharma.com
Previous reportsAll values in CNY
Loading Previous Earnings...
Revenue
Net income
All values in CNY
Dec 2025
Mar 2026
Jun 2026
Sep 2026
Revenue
1.35B
1.20B
1.37B
1.36B
Cost of goods sold
1.05B
763.95M
887.73M
860.85M
Cost of revenue
1.05B
763.95M
887.73M
860.85M
Research and development expenses
62.23M
56.24M
73.35M
69.53M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
134.09M
131.90M
127.21M
116.84M
Operating expense
220.80M
199.95M
220.47M
188.98M
Total operating expenses
1.27B
963.90M
1.11B
1.05B
Operating income
79.57M
236.76M
266.38M
311.61M
Other non operating income
7.81M
-12.27M
11.69M
-38.07M
EBT including unusual items
9.64M
219.86M
265.57M
272.46M
EBT excluding unusual items
81.56M
234.29M
262.63M
311.27M
Income tax expense
29.78M
51.59M
53.15M
46.19M
Effective tax rate
308.74%
23.46%
20.01%
16.95%
Other operating expenses
18.43M
8.30M
16.03M
1.40M
Net income
-17.58M
172.08M
215.31M
229.39M
Net profit margin
-1.30%
14.33%
15.66%
16.85%
Earnings per share
-
-
-
-
Interest and investment income
11.44M
11.16M
11.93M
12.41M
Interest expense
-4.34M
-1.35M
-1.12M
-931.96K
Net interest expenses
7.09M
9.80M
10.81M
11.48M
Depreciation and amortization charges
-
-
-
-
EBITDA
181.68M
338.87M
374.56M
413.72M
Gain or loss from assets sale
5.16M
-
2.80M
-2.80M
Upcoming events
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google apps